1. Home
  2. OVID vs ABVE Comparison

OVID vs ABVE Comparison

Compare OVID & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • ABVE
  • Stock Information
  • Founded
  • OVID 2014
  • ABVE 2019
  • Country
  • OVID United States
  • ABVE Canada
  • Employees
  • OVID N/A
  • ABVE N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • OVID Health Care
  • ABVE Consumer Staples
  • Exchange
  • OVID Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • OVID 88.9M
  • ABVE 90.1M
  • IPO Year
  • OVID 2017
  • ABVE N/A
  • Fundamental
  • Price
  • OVID $1.72
  • ABVE $3.39
  • Analyst Decision
  • OVID Strong Buy
  • ABVE
  • Analyst Count
  • OVID 4
  • ABVE 0
  • Target Price
  • OVID $3.13
  • ABVE N/A
  • AVG Volume (30 Days)
  • OVID 5.1M
  • ABVE 3.2M
  • Earning Date
  • OVID 11-11-2025
  • ABVE 01-01-0001
  • Dividend Yield
  • OVID N/A
  • ABVE N/A
  • EPS Growth
  • OVID N/A
  • ABVE N/A
  • EPS
  • OVID N/A
  • ABVE N/A
  • Revenue
  • OVID $6,651,000.00
  • ABVE $213,446,206.00
  • Revenue This Year
  • OVID $1,086.57
  • ABVE N/A
  • Revenue Next Year
  • OVID N/A
  • ABVE N/A
  • P/E Ratio
  • OVID N/A
  • ABVE N/A
  • Revenue Growth
  • OVID 1070.95
  • ABVE N/A
  • 52 Week Low
  • OVID $0.24
  • ABVE $0.25
  • 52 Week High
  • OVID $2.01
  • ABVE $4.40
  • Technical
  • Relative Strength Index (RSI)
  • OVID 63.50
  • ABVE 80.24
  • Support Level
  • OVID $1.24
  • ABVE $1.56
  • Resistance Level
  • OVID $2.01
  • ABVE $3.53
  • Average True Range (ATR)
  • OVID 0.20
  • ABVE 0.30
  • MACD
  • OVID 0.03
  • ABVE 0.20
  • Stochastic Oscillator
  • OVID 66.29
  • ABVE 94.67

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: